CN102940846A - 一种用于治疗萎缩性胃炎的中药组合物及其制备方法和应用 - Google Patents
一种用于治疗萎缩性胃炎的中药组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN102940846A CN102940846A CN2012105257751A CN201210525775A CN102940846A CN 102940846 A CN102940846 A CN 102940846A CN 2012105257751 A CN2012105257751 A CN 2012105257751A CN 201210525775 A CN201210525775 A CN 201210525775A CN 102940846 A CN102940846 A CN 102940846A
- Authority
- CN
- China
- Prior art keywords
- parts
- atrophic gastritis
- chinese medicine
- medicine composition
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000004300 Atrophic Gastritis Diseases 0.000 title claims abstract description 42
- 208000036495 Gastritis atrophic Diseases 0.000 title claims abstract description 42
- 208000016644 chronic atrophic gastritis Diseases 0.000 title claims abstract description 42
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 210000000582 semen Anatomy 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 3
- 241001522129 Pinellia Species 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000012567 medical material Substances 0.000 claims description 19
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 239000002671 adjuvant Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 8
- 230000006837 decompression Effects 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 244000124853 Perilla frutescens Species 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 235000004347 Perilla Nutrition 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 229940010454 licorice Drugs 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 240000003870 Ageratum houstonianum Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 240000002943 Elettaria cardamomum Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000005300 cardamomo Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 10
- 241000700159 Rattus Species 0.000 description 8
- 210000001156 gastric mucosa Anatomy 0.000 description 6
- 206010003694 Atrophy Diseases 0.000 description 5
- 230000037444 atrophy Effects 0.000 description 5
- 210000004907 gland Anatomy 0.000 description 5
- 210000004877 mucosa Anatomy 0.000 description 5
- 238000004064 recycling Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 206010020718 hyperplasia Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 102000057297 Pepsin A Human genes 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 2
- 206010054949 Metaplasia Diseases 0.000 description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000015689 metaplastic ossification Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 229960004025 sodium salicylate Drugs 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- LVRVABPNVHYXRT-BQWXUCBYSA-N 52906-92-0 Chemical compound C([C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)C1=CC=CC=C1 LVRVABPNVHYXRT-BQWXUCBYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102400000921 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 101800002372 Motilin Proteins 0.000 description 1
- 102400001357 Motilin Human genes 0.000 description 1
- 206010061297 Mucosal erosion Diseases 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229950005162 benexate Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- IAXUQWSLRKIRFR-SAABIXHNSA-N chembl2104696 Chemical compound C1C[C@@H](CNC(=N)N)CC[C@@H]1C(=O)OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IAXUQWSLRKIRFR-SAABIXHNSA-N 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210525775.1A CN102940846B (zh) | 2012-12-08 | 2012-12-08 | 一种用于治疗萎缩性胃炎的中药组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210525775.1A CN102940846B (zh) | 2012-12-08 | 2012-12-08 | 一种用于治疗萎缩性胃炎的中药组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102940846A true CN102940846A (zh) | 2013-02-27 |
CN102940846B CN102940846B (zh) | 2014-08-27 |
Family
ID=47723906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210525775.1A Expired - Fee Related CN102940846B (zh) | 2012-12-08 | 2012-12-08 | 一种用于治疗萎缩性胃炎的中药组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102940846B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103536638A (zh) * | 2013-10-22 | 2014-01-29 | 第三军医大学第二附属医院 | 一种治疗胃肠功能紊乱的药物及其制备方法 |
CN104208504A (zh) * | 2014-08-25 | 2014-12-17 | 闫立海 | 一种用于治疗胃病的中药组合物 |
CN104306544A (zh) * | 2014-11-09 | 2015-01-28 | 朱海燕 | 一种用于治疗慢性萎缩性胃炎的中药组合物及其制备方法和应用 |
CN105232841A (zh) * | 2014-06-15 | 2016-01-13 | 骆红斌 | 一种治疗胃炎的药物 |
CN106421546A (zh) * | 2016-10-14 | 2017-02-22 | 全椒先奇医药科技有限公司 | 一种治疗萎缩性胃炎中药组合物及其制备方法 |
CN107582686A (zh) * | 2017-10-07 | 2018-01-16 | 南京正宽医药科技有限公司 | 一种用于治疗胃炎的中药组合物及其制备方法和应用 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1080534A (zh) * | 1992-06-29 | 1994-01-12 | 韩保生 | 治疗萎缩性胃炎中药生产方法 |
CN1174717A (zh) * | 1996-08-23 | 1998-03-04 | 李建华 | 一种治疗胃病的中药 |
CN1300612A (zh) * | 2000-12-27 | 2001-06-27 | 侯文平 | 胃疾药及制法 |
CN1739783A (zh) * | 2005-09-16 | 2006-03-01 | 王俊 | 一种治疗胃炎、胃溃疡、十二指肠溃疡的中药组合物 |
CN1742952A (zh) * | 2004-08-30 | 2006-03-08 | 王庆学 | 治疗慢性萎缩性胃炎专用中药及其制作方法 |
CN101524520A (zh) * | 2008-03-06 | 2009-09-09 | 北京中科仁和科技有限公司 | 一种抗慢性胃炎的中药组合物及其制备方法 |
CN101912564A (zh) * | 2010-09-07 | 2010-12-15 | 董宇翔 | 一种治疗慢性胃炎的中药 |
CN101954048A (zh) * | 2010-10-15 | 2011-01-26 | 胡一莉 | 一种治疗萎缩性胃炎伴癌前病变的中药配方 |
CN102293960A (zh) * | 2011-06-27 | 2011-12-28 | 荣成市崖头美全口腔诊所 | 一种治疗胃炎的中药 |
CN102406891A (zh) * | 2011-11-22 | 2012-04-11 | 荣成市交通诊所 | 一种治疗肝郁引起萎缩性胃炎的中药组合物 |
CN102772752A (zh) * | 2012-06-14 | 2012-11-14 | 张红 | 一种治疗萎缩性胃炎的中药复合口服液 |
-
2012
- 2012-12-08 CN CN201210525775.1A patent/CN102940846B/zh not_active Expired - Fee Related
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1080534A (zh) * | 1992-06-29 | 1994-01-12 | 韩保生 | 治疗萎缩性胃炎中药生产方法 |
CN1174717A (zh) * | 1996-08-23 | 1998-03-04 | 李建华 | 一种治疗胃病的中药 |
CN1300612A (zh) * | 2000-12-27 | 2001-06-27 | 侯文平 | 胃疾药及制法 |
CN1742952A (zh) * | 2004-08-30 | 2006-03-08 | 王庆学 | 治疗慢性萎缩性胃炎专用中药及其制作方法 |
CN1739783A (zh) * | 2005-09-16 | 2006-03-01 | 王俊 | 一种治疗胃炎、胃溃疡、十二指肠溃疡的中药组合物 |
CN101524520A (zh) * | 2008-03-06 | 2009-09-09 | 北京中科仁和科技有限公司 | 一种抗慢性胃炎的中药组合物及其制备方法 |
CN101912564A (zh) * | 2010-09-07 | 2010-12-15 | 董宇翔 | 一种治疗慢性胃炎的中药 |
CN101954048A (zh) * | 2010-10-15 | 2011-01-26 | 胡一莉 | 一种治疗萎缩性胃炎伴癌前病变的中药配方 |
CN102293960A (zh) * | 2011-06-27 | 2011-12-28 | 荣成市崖头美全口腔诊所 | 一种治疗胃炎的中药 |
CN102406891A (zh) * | 2011-11-22 | 2012-04-11 | 荣成市交通诊所 | 一种治疗肝郁引起萎缩性胃炎的中药组合物 |
CN102772752A (zh) * | 2012-06-14 | 2012-11-14 | 张红 | 一种治疗萎缩性胃炎的中药复合口服液 |
Non-Patent Citations (1)
Title |
---|
王仁英: "萎缩性胃炎的中医药治疗", 《安徽中医临床杂志》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103536638A (zh) * | 2013-10-22 | 2014-01-29 | 第三军医大学第二附属医院 | 一种治疗胃肠功能紊乱的药物及其制备方法 |
CN103536638B (zh) * | 2013-10-22 | 2017-06-13 | 中国人民解放军第三军医大学第二附属医院 | 一种治疗胃肠功能紊乱的药物及其制备方法 |
CN105232841A (zh) * | 2014-06-15 | 2016-01-13 | 骆红斌 | 一种治疗胃炎的药物 |
CN104208504A (zh) * | 2014-08-25 | 2014-12-17 | 闫立海 | 一种用于治疗胃病的中药组合物 |
CN104306544A (zh) * | 2014-11-09 | 2015-01-28 | 朱海燕 | 一种用于治疗慢性萎缩性胃炎的中药组合物及其制备方法和应用 |
CN106421546A (zh) * | 2016-10-14 | 2017-02-22 | 全椒先奇医药科技有限公司 | 一种治疗萎缩性胃炎中药组合物及其制备方法 |
CN107582686A (zh) * | 2017-10-07 | 2018-01-16 | 南京正宽医药科技有限公司 | 一种用于治疗胃炎的中药组合物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102940846B (zh) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102940846B (zh) | 一种用于治疗萎缩性胃炎的中药组合物及其制备方法和应用 | |
CN102895432A (zh) | 开心散新剂型处方工艺及其制备方法 | |
CN101002927A (zh) | 一种治疗慢性溃疡性结肠炎的中药结肠溶胶囊的组成及其制备方法 | |
CN102258680B (zh) | 一种缓解体力疲劳的中药组合物及其制备方法和应用 | |
CN103800823A (zh) | 用于消除结石的内服中药组合物及其制备方法 | |
CN102935187A (zh) | 一种用于治疗慢性萎缩性胃炎的中药组合物及其制备方法和应用 | |
CN107913391B (zh) | 一种用于治疗非糜烂性胃食管反流病的药物组合物及其制备方法和应用 | |
CN102940845B (zh) | 一种用于治疗胃炎的中药组合物及其制备方法和应用 | |
CN111700938A (zh) | 一种用于治疗胰腺炎和胰腺假性囊肿的中药组合物 | |
CN104001004A (zh) | 一种治疗骨折和骨质疏松的中药组合物及其制备方法和应用 | |
CN102935177B (zh) | 一种用于治疗干燥综合症的中药组合物及制备方法和应用 | |
CN103301279A (zh) | 一种防治牛前胃疾病的中药及其复方口服片剂的制备方法 | |
CN102204978A (zh) | 一种治疗癌性疼痛的药物组合物及其制剂 | |
CN102258583B (zh) | 一种治疗慢性非特异性溃疡性结肠炎中药制剂及其制备方法 | |
CN104000883B (zh) | 一种治疗胃炎的片剂及其制备方法和应用 | |
CN101194945A (zh) | 一种治疗头痛的片剂及其制备方法 | |
CN101327293A (zh) | 一种治疗消化性溃疡的胶囊及其制备方法 | |
CN111388584A (zh) | 一种治疗阳痿的组合物及其制备方法 | |
CN102579863B (zh) | 中药口服贴片、及其制备方法 | |
CN108079089B (zh) | 一种治疗糖尿病肾病的中药组合物及其制备方法 | |
CN105396107A (zh) | 一种治疗肠胃炎的中药组合物 | |
CN101264208A (zh) | 用于治疗胃肠功能紊乱的药物组合物及其制备方法 | |
CN104306528A (zh) | 一种用于治疗胃炎的中药组合物及其制备方法和应用 | |
CN104800805A (zh) | 一种治疗尿频的药物 | |
CN104352606A (zh) | 以毒攻毒治疗食管癌的制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YANTAI AFFILIATED HOSPITAL OF BINZHOU MEDICAL UNIV Free format text: FORMER OWNER: NANJING ZHENGKUAN PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. Effective date: 20140730 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Jia Shushan Inventor after: Shang Li Inventor after: Ni Tianhui Inventor after: Wang Binsheng Inventor after: Liu Qiang Inventor after: Wang Fang Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: JIA SHUSHAN SHANG LI NI TIANHUI WANG BINSHENG LIU QIANG WANG FANG Free format text: CORRECT: ADDRESS; FROM: 211224 NANJING, JIANGSU PROVINCE TO: 264100 YANTAI, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140730 Address after: 264100, No. 717 port Avenue, Muping District, Shandong, Yantai Applicant after: Yantai Affiliated Hospital of Binzhou Medical University Address before: 211224 No. 1 Industrial Park, Jing Qiao Town, Lishui County, Jiangsu, Nanjing Applicant before: Nanjing Zhengkuan Pharmaceutical Science and Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140827 Termination date: 20161208 |